logo

For the Inventor, By the Inventor

Hokkaido, Japan

Taku Tanaka

This inventor holds 6 USPTO granted patents and 1 published patent application. Top assignees: Sony Computer Entertainment Inc., Sony Corporation, National Center for Child Health and Development. Active years: 1999-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Taku Tanaka. Retrieved from https://idiyas.com/inventor/taku-tanaka-m3xkxmt2

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 6 

% Patents Active = 83.3

Average Co-Inventor Count = 3.3

ph-index = 4

Forward Citations = 36(Granted Patents)


Location History:

  • Hokkaido, JP (2010 - 2014)
  • Tokyo, JP (1999 - 2024)

Company Filing History:

goldMedal3 out of 1,799 
 
Sony Computer Entertainment Inc.
 patents
silverMedal3 out of 58,148 
 
Sony Corporation
 patents
bronzeMedal2 out of 15 
 
National Center for Child Health and Development
 patents
4. 2 out of 229 
 
Senju Pharmaceutical Co., Ltd.
 patents
where one patent can have more than one assignee

Years Active: 1999-2024

Loading Chart...
6 patents (USPTO):Explore Patents
1. 12024714 - Method for preparation of retinal ganglion cells (2024-07-02),
2. 10584314 - Method for preparation of retinal ganglion cells (2020-03-10),
3. 8671152 - Network processor system and network protocol processing method (2014-03-11),
4. 8175116 - Multiprocessor system for aggregation or concatenation of packets (2012-05-08),
5. 7783810 - Apparatus and method of processing information (2010-08-24),
6. 5954795 - Method of and apparatus for reducing server and network load with (1999-09-21),

Title: Taku Tanaka: Innovator in Retinal Ganglion Cell Preparation

Introduction

Taku Tanaka is a prominent inventor based in Hokkaido, Japan. He has made significant contributions to the field of stem cell research, particularly in the preparation of retinal ganglion cells. With a total of six patents to his name, Tanaka's work is paving the way for advancements in clinical applications.

Latest Patents

One of Tanaka's latest patents is a method for the preparation of retinal ganglion cells. The objective of this invention is to provide a method for inducing pluripotent stem cells to differentiate into clinically applicable retinal ganglion cells. This innovative method involves several steps: first, inducing pluripotent stem cells to differentiate into retinal progenitor cells via floating culture; second, inducing the retinal progenitor cells to differentiate into retinal ganglion cells through floating culture; and finally, allowing the axons of the retinal ganglion cells to elongate via adhesion culture.

Career Highlights

Throughout his career, Taku Tanaka has worked with notable companies such as Sony Corporation and Sony Computer Entertainment Inc. His experience in these organizations has contributed to his expertise in the field of innovation and invention.

Collaborations

Tanaka has collaborated with esteemed colleagues, including Kazuyoshi Horie and Kazutaka Tachibana. These partnerships have further enhanced his research and development efforts in the area of

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…